Study design of an efficacy and safety phase 3, randomized, double-blind, placebo-controlled trial of APL-130277 in the treatment of OFF episodes (CTH-300)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 1, 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1106 Human Movement and Sports Sciences (FoR)
- 1109 Neurosciences (FoR)
- Neurology & Neurosurgery (Science Metrix)
published in
- Movement Disorders Journal